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1. Introduction 
Protein S5 plays an important role in both assembly 
and function of the small ribosomal subunit. 30 S 
subunits reconstituted in the absence of protein SS 
sediment at 28 S and are only 30-50% active in 
the in vitro poly (U)-directed polyphenylalanine 
synthesis system. The ability of these depleted parti- 
cles to bind fMet-tRNA in the presence of AUG and 
IF-2 is drastically reduced [ 11. These data are in good 
agreement with antibody-blocking experiments: anti- 
S5 is a strong inhibitor of the translation of natural 
and synthetic mRNA and exhibits these effects 
mainly by inhibition of the initiation step [2]. 
Furthermore, protein S5 is, together with proteins S2 
and S9, implied in the association of ribosomal 
subunits and stimulates the EF-G-dependent GTPase 
activity [3]. On the other hand, specific antibodies 
to protein S5 inhibit neither subunit reassociation [4] 
nor EF-G-dependent GTP-hydrolysis [ 51. 
Hydrodynamic studies on isolated protein S5 
revealed an elongated shape of this protein [6,7]. 
A more compact structure for S5 was deduced 
from neutron scattering experiments [8]. Three anti- 
body binding sites have been detected on the 30 S 
subunit by immune electron microscopy [9]: one of 
these sites is located in the lower region of the head, 
a second in the neck region and a third at the upper 
part of one of the lobes of the small subunit. 
Protein S5, besides protein S7, differs among 
various Eschenkhia coli strains [lo], and altered S5 
proteins have been detected in a great variety of 
mutants: 
(i) In spectinomycin resistant mutants [ 111; 
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(ii) In revertants from streptomycin dependence to 
independence [ 12- 141; 
(iii) In cold-sensitive [ 1.51 and temperature-sensitive 
[ 161 mutants; 
(iv) In mutants suppressing a defect alanyl-tRNA 
synthetase [ 171; 
(v) In neamine resistant mutants [ 181. 
In this paper the complete primary structure of 
protein S5 is presented, and predictions for the 
secondary structure of this protein are made based 
on four different computer programmes. Further- 
more, the sequence of protein S5 is compared for 
homology with 40 other E. coli proteins of known 
primary structure. Finally, the determination of 
the sequence of S5 allows the exact localization of 
the amino acid exchanges in the S5 protein chains 
which are altered in the different types of mutants 
mentioned above. The results obtained so far with 
the mutants are summarized at the end of this paper. 
2. Materials and methods 
Protein S5 was isolated from E. coli K strain A 19 
as in [ 191 and provided by Dr H. G. Wittmann. The 
identity and purity of the protein were checked by 
two-dimensional polyacrylamide gel electrophoresis 
PI. 
Enzymatic digestions of the protein with trypsin, 
o-chymotrypsin and thermolysin were performed by 
preincubation of the water-soluble protein with these 
enzymes at neutral pH and 37’C for 0.5-l h before 
adding dropwise 0.2 M N-methyl-morpholine acetate 
buffer (pH 8.1) or dilute ammonia to reach a final 
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Fig.1, continued 
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Fig.1. The primary structure of protein SSK from Escherz8zi~ coli. Abbreviations: Tryp, trypsin digestion (peptides T); ETPA, 
trypsin digestion after blocking the amino groups by ETPA (peptides ET); CNBr, cleavage with cyanogen bromide (peptides CN); 
SP, digestion with Staphylococcus uureus protease; CHYM, digestion with cYchymotrypsin (peptides CH); THER, digestion with 
thermolysin (peptides TH). 
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pH of 7.8-8.0. Digestions with trypsin were then 
done for 4 h, with chymotrypsin for l-3.5 h at 37’C 
and with thermolysin for 2 h at 37’C or 55’C. 
Furthermore, tryptic digestions were made after 
blocking of the e-amino groups of the lysines with 
exocis3,6-endoxod4-tetrahydrophthalic 
anhydride (ETPA) [2 1,221. Cleavage with Staphylo- 
coccus aureus protease was done in 50 mM 
ammonium acetate buffer at pH 4.0 for 24-48 h at 
37’C [23]. Digestions with carboxypeptidase A and 
B were performed at pH 7.8 and 37°C. The protein 
was digested between 10 min and 4 h and peptides 
for 2-4 h. Cleavage with cyanogen bromide was 
made in 70% formic acid at 37°C for 24-48 h with a 
loo-fold molar excess of the reagent over methionine. 
Separation of the peptides was achieved by 
chromatography on sulfoethyl-cellulose columns [24], 
on Dowex M7 1 micro columns [ 251 and by the 
fingerprint technique using cellulose thin-layer sheets 
[22]. The tryptic peptide T20 was isolated as a sedi- 
ment from the lyophilized tryptic digestion which 
was dissolved in water. Larger peptides, mainly 
deriving from Staph. aureus protease digestion and 
cyanogen bromide treatment, were fractionated by 
gel filtration on Sephadex G-50, G-75 and G-100 
in 10% acetic acid or 20% pyridine. The smaller pep- 
tides eluted from these Sephadex column runs were 
further purified by one-dimensional thin-layer chro- 
matography or by the thin-layer fingerprint tech- 
nique. Amino acid analyses were done on a Durrum 
D-500 or LKB 3201 analyzer as detailed in [22]. 
Sequencing of the various peptides was performed 
by the following methods: 
(i) Manual Edman degradation combined with 
dansylation of the free N-terminal amino acid 
residue after each degradation cycle [26,27]. 
In cases of Glu/Gln and Asp/Asn the released 
thiazolinones were manually converted to the 
PTH-amino acids which were identified by 
thin-layer chromatography or electrophoresis. 
(ii) Solid-phase sequencing [28] with attachment of 
the C-terminal carboxyl groups of the peptides to 
aminopolystyrene resin by means of a water- 
soluble carbddiimide [ 291. The thiazolinones 
were converted to the PTH-amino acids with 
20% TFA and were identified by thin-layer 
chromatography on silica gel sheets [30]. 
(iii) Insoluble and large peptides were sequenced by 
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automated Edman degradation with the liquid- 
phase technique [3 l] using an improved 
Beckman sequencer together with automated 
conversion device (reviewed in [32]). The PTH- 
amino acids were identified by thin-layer chro- 
matography as in [30]. 
3. Results and discussion 
3.1. Sequence determination 
Protein S5 was subjected to digestion with various 
proteases and to chemical cleavage employing 
cyanogen bromide. The resulting peptides which are 
shown in fig. 1 were isolated by a combination of 
column chromatography, sulfoethyl-cellulose, Dowex 
M71 micro method, or gel filtration on Sephadex 
with thin-layer chromatography or fingerprint tech- 
nique . 
All tryptic peptides, except T6 and T20, were 
sequenced by the manual dansyl-Edman technique 
and by the solid-phase method with attachment of 
the C-terminal carboxyl group of the peptides to 
amino-polystyrene resin. Tryptic peptide T20, which 
was insoluble in dilute buffer solutions, was sequenced 
in the improved Beckman sequenator. 
The peptides deriving from the other cleavages 
were mainly sequenced by the dansyl-Edman tech- 
nique. Peptide SP4 (position 65-100) was degraded 
in the liquid-phase sequencer (up to position 83). The 
sequence of SP9 (position 15 1 - 16 l/ 162) and the 
N-terminal sequence of peptide SP6 (position 
116-144) up to position 127 were obtained by 
means of the solid-phase method. 
Peptide T6, located at the N-terminus of wild-type 
protein S5, could not be degraded by the Edman 
method because it has a blocked N-terminus. How- 
ever, several mutants with altered S5 protein were 
found to have unblocked N-terminus [33]. The 
N-terminal peptides T6 of these mutants were 
sequenced by the solid-phase technique and gave the 
sequence shown in fig.1. 
Knowing that the amino acid composition of wild- 
type T6 was the same as that of mutant T6, we 
further studied wild-type T6 with blocked N-terminus 
by digestion of the peptide with thermolysin which 
released two fragments: T6-THa (Alar , His1 ) and 
T6-THb (Ile-Glu-Lys); the sequence of the latter 
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was obtained by dansyl-Edman degradation. T6-THa 
was treated with carboxypeptidase B which resulted 
in free histidine. The carboxypeptidase digest was 
chromatographed on a thin-layer cellulose sheet, and 
diverse zones, not staining with ninhydrin reagent, 
were eluted for amino acid analysis. A zone con- 
taining only alanine, which co-chromatographed with 
authentic N-mono-acetyl-alanine was examined in a 
Varian CH+7 mass spectrometer provided with an 
electron impact ionic source. The alanine containing 
zone gave the molecular ion [M + I]* at m/e = 132 
and the [M + 2]+ ion at m/e = 133. In addition, the 
thermolytic peptide T6-THa was directly analyzed in 
a Varian 3 11 mass spectrometer employing the field 
desorption technique. The molecular mass ion of 
N-mono-acetyl-alanyl-histidine [M + 1 ] at m/e = 269 
was obtained. 
3.2. Alignment of the isolated peptides 
The alignment of the tryptic peptides T6-T5- 
T8-T 1 O-T 11 -T 14-T20 in the N-terminal region 
of the protein chain was made by combining the 
sequence results on Staph. aureus protease, chymo- 
trypsin and thermolysin peptides. It was confirmed 
by liquid-phase sequencing of the unblocked S5 
protein derived from mutant JE386 [33] up to posi- 
tion 34. In addition, the adjacent positions of peptide 
T8-TlO were known from protein-chemical studies 
on the protein S5 from mutant spcRmy [34] in which 
Arg, 9 of T8 is replaced by leucine resulting in the 
tryptic ‘bridge-peptide’ T8-TIO. 
The alignment of the tryptic peptides T20-T13- 
T15--T3-T7 was obtained from peptides CH7, CH9 
and TH14. The sequence of CN2 and the N-terminal 
sequence of SP4 provided the alignment of T7-T15- 
T18-T17. Chymotryptic peptide CH14 served as 
a bridge for T17-T19 and peptide CH15 for 
T19-T2. 
The order of T2-T 16 was known from mutants of 
S5 in which Argr 1 1 is replaced by leucine in the 
mutant N-421 [35] and in d-1023 [36]. The same 
result came from analysis of mutant nea3 19 where 
this arginine residue is replaced by serine and from 
nea3 14 where it is exchanged by glycine [37]. 
The order of peptides T16-T9-Tl-T18-T12- 
T4 derived from the sequence of CH20, the composi- 
tion and the liquid-phase sequencing of peptide SP6 
as well as solid-phase sequencing of peptide SP9 and 
CN7. This alignment is in good agreement with results 
from treatment of the intact protein S5 with car- 
boxypeptidase A and B, which releases lysine, gly- 
tine, leucine and isoleucine. Furthermore, the mutant 
sup O-1 has a shortened S5 protein chain with a 
smaller peptide T4 than in the wild-type [35]. 
3.3. The primap structure of protein S5 
Combination of all results, which will be detailed 
elsewhere, led to the primary structure of protein S5 
of E. coli as shown in fig. 1. Protein S5 has 166 amino 
acid residues and the composition derived from the 
sequence is: Asp* Asnr 1 Thrs Ser, Glur 1 Gins Pros 
Gly,i Alaze Va1i9 Met6 Belo Leus Tyra Phe4 His4 
Lysls Argie. Tryptophan and cysteine have not been 
found by the appropriate methods for their detec- 
tion. The blocked N-terminus of S5 was identified as 
N-mono-acetyl-alanine. The molecular weight cal- 
culated on the basis of the sequence given in fig.1 is 
17 515. 
The protein has a tendency to precipitate at pH 
7.5-8.0. Therefore complete cleavages with trypsin, 
thermolysin and chymotrypsin were only obtained 
by preincubating the protein with these enzymes in 
water prior to the adjustment of the optimal pH for 
the digestion. 
Cleavage with Staph. aureus protease and 
cyanogen bromide mainly gave large fragments which 
were heterogeneous at their N- or C-terminal part, 
e.g., SP3/SP2-3 and SP6/7/8 (see fig.1). Therefore 
the yield of individual fragments was rather low and 
made only N-terminal sequence studies possible. 
3.4. Secondary structure of protein S5 
In fig.2 the secondary structure of protein S5 is 
presented as predicted by four different methods 
detailed in [38]. In the line ‘PRE’ of fig.2, regions 
for helix, extended structure and P-turns are indicated 
provided that at least three out of four methods are 
in agreement. Based on this prediction, protein S5 
contains at least 34% helix, 18% &turns and 8% 
extended structure. 
3.5. Comparison of protein S5 with other ribosomal 
proteins 
Comparison of S5 with other E. coli ribosomal 
proteins of known sequences revealed that a penta- 
peptide is identical in S5 and S14 and another penta- 
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Fig.2. Secondary structure of ribosomal protein S5 predicted according to four different methods (detailed in [38]). The sym- 
bols represent residues in helical (Q), P-turn or loops (t ), extended (w) and coil (-_) conformational states, respectively. The 
diagram denoted by ‘PRE’ summarises the secondary structure obtained when three out of four predictions are in agreement. 
A meansi+mono-acetyl-alanine. 
peptide in S5 and L29. Each of eight tetrapeptides of Tl of S5B enabled us now to locate alanine at posi- 
S5 were also found in proteins S2, S3, S4, S 16, S20, tion 150 replacing glutamic acid of S5K. The N-ter- 
L4, L14, L23 and three tetrapeptides are shared with minal regions of proteins S5 from E. coli (fig. 1) and 
protein L24. Furthermore, the following stretch of Bacillus stearothermophilus ([39], M. Yaguchi, per- 
sequences occurs both in S5 and S9: . . . Glu-Lys . . . sonal communication) are compared in fig.3. Identi- 
Glu-Lys-Leu . . . Thr-Val-Lys-Gly-Gly . . . Lys- cal amino acids occur in -50% of the 30 positions 
Ala-Arg-Arg . . . sequenced so far in both proteins. 
3.6. Comparison of proteins S5 from two E. coli 3.7. Amino acid replacements in mutationally altered 
strains S5 proteins 
From the analysis of the tryptic peptides of pro- 
teins S5 isolated from the E. coIi strains K and B it 
became obvious that one glutamic acid residue in 
S5K is replaced by alanine in the tryptic peptide Tl 
of S5B [24]. Solid-phase degradation of the peptide 
Ten mutants with altered S5 proteins have been 
studied up to now by protein-chemical methods. The 
results are summarized in fig.4. Similar to mutants 
altered in protein S12 [40], the amino acid exchanges 
in mutationally altered S5 proteins are clustered in a 
1 5 10 15 
E.coli [/Tcr&fHiseGlu-Lys-Gln-Ala-Gly 
B.stearo. ~~~~~~~~~~~~tArg~~p-Pro-Asn-Lys-Leu~Glx-Leu-GLx-Glx~Arg-Val-Val- _ - _ 
20 25 30 
E.coli ~~~Ser-fi&Thr~Val-Lys-Gly-Gly -Arg+l le- Phe - 
Estearo. ~Ala~~Ala~Val~Val-Lys-Gly-Gly-ArgEArg 
Fig.3. Comparison of N-terminal sequences of protein S5 from E. cob and Bacillus stearothermophilus. 
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RIBOSOMAL PROTEIN S5 FROM E.COLI : WILDTYPE AND MUTANTS 
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Fig.4. Amino acid replacements in mutationally altered S5 proteins. The alignment of the tryptic peptides is presented together 
with the positions where the amino acid exchanges have been localised. 
few regions of the protein chain; in positions 19-21 
for four spectinomycin-resistant mutants [34,41,42]: 
in positions 103 and 111 for three revertants from 
streptomycin-dependence to independence [35,36] 
and in position 111 for two neamycin-resistant mu- 
tants [37]. Protein S5 of mutant sup O-1 in which 
the temperature-sensitive ph notype of an alanyl- 
tRNA synthetase mutation is partially suppressed, 
is shortened by five amino acids at the C-terminus 
and terminates with -Ser-Val-Gly [35]. Finally, 
mutants have recently been isolated whose N-termi- 
nus is not acetylated [33]. 
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